Assessing the impact of the introduction of generic methadone to the Ontario public drug formulary.
- DOI
- 10.1016/j.drugpo.2025.104918
- Published
- 2025-07-10
- Container
- Int J Drug Policy
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.drugpo.2025.104918,
title = {Assessing the impact of the introduction of generic methadone to the Ontario public drug formulary.},
author = {Hamzat B and Wang T and Garg R and Iacono A and Tadrous M and Wu F and Wyman J and Dodd Z and Pinkerton S and Smoke A and Gomes T.},
year = {2025},
journal = {Int J Drug Policy},
doi = {10.1016/j.drugpo.2025.104918},
url = {https://doi.org/10.1016/j.drugpo.2025.104918}
}RIS
TY - JOUR TI - Assessing the impact of the introduction of generic methadone to the Ontario public drug formulary. AU - Hamzat B AU - Wang T AU - Garg R AU - Iacono A AU - Tadrous M AU - Wu F AU - Wyman J AU - Dodd Z AU - Pinkerton S AU - Smoke A AU - Gomes T. PY - 2025 JO - Int J Drug Policy DO - 10.1016/j.drugpo.2025.104918 UR - https://doi.org/10.1016/j.drugpo.2025.104918 ER -
APA
B, H., T, W., R, G., A, I., M, T., F, W., J, W., Z, D., S, P., A, S., & T., G. (2025). Assessing the impact of the introduction of generic methadone to the Ontario public drug formulary.. Int J Drug Policy. https://doi.org/10.1016/j.drugpo.2025.104918
Source records
- europe-pmc · retrieved 2026-09-27T00:23:19.718Z